NeoGenomics Inc logo

NeoGenomics Inc

$ 9.25 +0.54 (+6.2%) 04:00 PM EST
On watch
P/E:
At Loss
P/B:
1.11
Market Cap:
$ 1.16B
Enterprise V:
$ 1.24B
Volume:
1.07M
Avg Vol (2M):
1.34M
Also Trade In:
Volume:
1.07M
Market Cap $:
1.16B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.34M
Enterprise Value $:
1.24B
PB Ratio:
1.11
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.
Name Current Vs Industry Vs History
Cash-To-Debt 0.76
Equity-to-Asset 0.58
Debt-to-Equity 0.59
Debt-to-EBITDA -6.9
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.15
Distress
Grey
Safe
Beneish M-Score -2.69
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.2
9-Day RSI 36.86
14-Day RSI 38.83
6-1 Month Momentum % -20.84
12-1 Month Momentum % -79.79

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.53
Quick Ratio 7.26
Cash Ratio 5.64
Days Inventory 26.06
Days Sales Outstanding 81.38
Days Payable 24.79

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.5

Financials (Next Earnings Date:2022-11-04 Est.)

NEO's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NEO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 489.313
EPS (TTM) ($) -1.19
Beta 1.11
Volatility % 61.8
14-Day RSI 38.83
14-Day ATR ($) 0.591829
20-Day SMA ($) 9.5705
12-1 Month Momentum % -79.79
52-Week Range ($) 6.85 - 47.67
Shares Outstanding (Mil) 125.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NeoGenomics Inc Filings

Document Form Filing Date
No Filing Data

NeoGenomics Inc Analysis

Share your research

Headlines

See More
No news.